Inloggad som:

avslutad_DAHLIA

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
avslutad_DAHLIA
A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF ABP 959 COMPARED WITH ECULIZUMAB IN ADULT SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF ABP 959 COMPARED WITH ECULIZUMAB IN ADULT SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
PLACEHOLDER
Mer information om studien för vårdgivare
Behandling
Fas 3
Kurativ
Företag
https://clinicaltrials.gov/ct2/show/NCT03818607

Studien ändrades senast av: studysonia (2023-05-10)

Tillbaka till listan